CN Patent

CN107205984B — 吡咯甲酰胺的固体组合物

Assigned to Daiichi Sankyo Co Ltd · Expires 2019-11-12 · 7y expired

What this patent protects

本发明的目的是提供一种稳定化的吡咯甲酰胺的固体组合物。实现该目的的方式是一种医药用固体组合物，其包含(S)‑1‑(2‑羟乙基)‑4‑甲基‑N‑[4‑(甲基磺酰基)苯基]‑5‑[2‑(三氟甲基)苯基]‑1H‑吡咯‑3‑甲酰胺以及合适的添加剂。

USPTO Abstract

本发明的目的是提供一种稳定化的吡咯甲酰胺的固体组合物。实现该目的的方式是一种医药用固体组合物，其包含(S)‑1‑(2‑羟乙基)‑4‑甲基‑N‑[4‑(甲基磺酰基)苯基]‑5‑[2‑(三氟甲基)苯基]‑1H‑吡咯‑3‑甲酰胺以及合适的添加剂。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN107205984B
Jurisdiction: CN
Classification: —
Expires: 2019-11-12
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.